The Leukemia & Lymphoma Society (LLS) is pleased to share a virtual lecture from our symposium held in conjunction with the Oncology Nursing Society’s 41st Annual Congress in San Antonio, TX on April 29, 2016. Click Here to view presentation.
We are sending this communication on behalf of Eli Lilly and Company to announce the assignment of a product‐specific Healthcare Common Procedure Coding System (HCPCS) code for Portrazza® (necitumumab) for injection. The new code, J9295, is defined as “injection, … Continued
INDICATION IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery. IMLYGIC has not been shown to improve overall survival or have … Continued